Home/Filings/4/0000899243-21-047342
4//SEC Filing

Thorpe Allen R 4

Accession 0000899243-21-047342

CIK 0001793294other

Filed

Dec 7, 7:00 PM ET

Accepted

Dec 8, 4:53 PM ET

Size

33.5 KB

Accession

0000899243-21-047342

Insider Transaction Report

Form 4
Period: 2021-12-08
Transactions
  • Sale

    Common Stock

    2021-12-08$47.50/sh20,244,387$961,608,3830 total(indirect: See Footnotes)
  • Sale

    Common Stock

    2021-12-08$47.50/sh35,622,429$1,692,065,3780 total(indirect: See Footnotes)
  • Sale

    Common Stock

    2021-12-08$47.50/sh934,469$44,387,2780 total(indirect: See Footnotes)
  • Sale

    Common Stock

    2021-12-08$47.50/sh52,884,036$2,511,991,7100 total(indirect: See Footnotes)
  • Sale

    Common Stock

    2021-12-08$47.50/sh15,987,409$759,401,9280 total(indirect: See Footnotes)
  • Sale

    Common Stock

    2021-12-08$47.50/sh3,630,740$172,460,1500 total(indirect: See Footnotes)
  • Sale

    Common Stock

    2021-12-08$47.50/sh157,138$7,464,0550 total(indirect: See Footnotes)
  • Sale

    Common Stock

    2021-12-08$47.50/sh359,372$17,070,1700 total(indirect: See Footnotes)
  • Sale

    Common Stock

    2021-12-08$47.50/sh3,021,286$143,511,0850 total(indirect: See Footnotes)
Transactions
  • Sale

    Common Stock

    2021-12-08$47.50/sh359,372$17,070,1700 total(indirect: See Footnotes)
  • Sale

    Common Stock

    2021-12-08$47.50/sh35,622,429$1,692,065,3780 total(indirect: See Footnotes)
  • Sale

    Common Stock

    2021-12-08$47.50/sh3,021,286$143,511,0850 total(indirect: See Footnotes)
  • Sale

    Common Stock

    2021-12-08$47.50/sh52,884,036$2,511,991,7100 total(indirect: See Footnotes)
  • Sale

    Common Stock

    2021-12-08$47.50/sh20,244,387$961,608,3830 total(indirect: See Footnotes)
  • Sale

    Common Stock

    2021-12-08$47.50/sh15,987,409$759,401,9280 total(indirect: See Footnotes)
  • Sale

    Common Stock

    2021-12-08$47.50/sh934,469$44,387,2780 total(indirect: See Footnotes)
  • Sale

    Common Stock

    2021-12-08$47.50/sh3,630,740$172,460,1500 total(indirect: See Footnotes)
  • Sale

    Common Stock

    2021-12-08$47.50/sh157,138$7,464,0550 total(indirect: See Footnotes)
Transactions
  • Sale

    Common Stock

    2021-12-08$47.50/sh3,021,286$143,511,0850 total(indirect: See Footnotes)
  • Sale

    Common Stock

    2021-12-08$47.50/sh52,884,036$2,511,991,7100 total(indirect: See Footnotes)
  • Sale

    Common Stock

    2021-12-08$47.50/sh359,372$17,070,1700 total(indirect: See Footnotes)
  • Sale

    Common Stock

    2021-12-08$47.50/sh35,622,429$1,692,065,3780 total(indirect: See Footnotes)
  • Sale

    Common Stock

    2021-12-08$47.50/sh20,244,387$961,608,3830 total(indirect: See Footnotes)
  • Sale

    Common Stock

    2021-12-08$47.50/sh15,987,409$759,401,9280 total(indirect: See Footnotes)
  • Sale

    Common Stock

    2021-12-08$47.50/sh3,630,740$172,460,1500 total(indirect: See Footnotes)
  • Sale

    Common Stock

    2021-12-08$47.50/sh934,469$44,387,2780 total(indirect: See Footnotes)
  • Sale

    Common Stock

    2021-12-08$47.50/sh157,138$7,464,0550 total(indirect: See Footnotes)
Transactions
  • Sale

    Common Stock

    2021-12-08$47.50/sh3,630,740$172,460,1500 total(indirect: See Footnotes)
  • Sale

    Common Stock

    2021-12-08$47.50/sh934,469$44,387,2780 total(indirect: See Footnotes)
  • Sale

    Common Stock

    2021-12-08$47.50/sh20,244,387$961,608,3830 total(indirect: See Footnotes)
  • Sale

    Common Stock

    2021-12-08$47.50/sh35,622,429$1,692,065,3780 total(indirect: See Footnotes)
  • Sale

    Common Stock

    2021-12-08$47.50/sh3,021,286$143,511,0850 total(indirect: See Footnotes)
  • Sale

    Common Stock

    2021-12-08$47.50/sh359,372$17,070,1700 total(indirect: See Footnotes)
  • Sale

    Common Stock

    2021-12-08$47.50/sh15,987,409$759,401,9280 total(indirect: See Footnotes)
  • Sale

    Common Stock

    2021-12-08$47.50/sh52,884,036$2,511,991,7100 total(indirect: See Footnotes)
  • Sale

    Common Stock

    2021-12-08$47.50/sh157,138$7,464,0550 total(indirect: See Footnotes)
Transactions
  • Sale

    Common Stock

    2021-12-08$47.50/sh359,372$17,070,1700 total(indirect: See Footnotes)
  • Sale

    Common Stock

    2021-12-08$47.50/sh3,630,740$172,460,1500 total(indirect: See Footnotes)
  • Sale

    Common Stock

    2021-12-08$47.50/sh52,884,036$2,511,991,7100 total(indirect: See Footnotes)
  • Sale

    Common Stock

    2021-12-08$47.50/sh157,138$7,464,0550 total(indirect: See Footnotes)
  • Sale

    Common Stock

    2021-12-08$47.50/sh35,622,429$1,692,065,3780 total(indirect: See Footnotes)
  • Sale

    Common Stock

    2021-12-08$47.50/sh3,021,286$143,511,0850 total(indirect: See Footnotes)
  • Sale

    Common Stock

    2021-12-08$47.50/sh934,469$44,387,2780 total(indirect: See Footnotes)
  • Sale

    Common Stock

    2021-12-08$47.50/sh20,244,387$961,608,3830 total(indirect: See Footnotes)
  • Sale

    Common Stock

    2021-12-08$47.50/sh15,987,409$759,401,9280 total(indirect: See Footnotes)
Transactions
  • Sale

    Common Stock

    2021-12-08$47.50/sh35,622,429$1,692,065,3780 total(indirect: See Footnotes)
  • Sale

    Common Stock

    2021-12-08$47.50/sh3,021,286$143,511,0850 total(indirect: See Footnotes)
  • Sale

    Common Stock

    2021-12-08$47.50/sh157,138$7,464,0550 total(indirect: See Footnotes)
  • Sale

    Common Stock

    2021-12-08$47.50/sh359,372$17,070,1700 total(indirect: See Footnotes)
  • Sale

    Common Stock

    2021-12-08$47.50/sh15,987,409$759,401,9280 total(indirect: See Footnotes)
  • Sale

    Common Stock

    2021-12-08$47.50/sh934,469$44,387,2780 total(indirect: See Footnotes)
  • Sale

    Common Stock

    2021-12-08$47.50/sh52,884,036$2,511,991,7100 total(indirect: See Footnotes)
  • Sale

    Common Stock

    2021-12-08$47.50/sh20,244,387$961,608,3830 total(indirect: See Footnotes)
  • Sale

    Common Stock

    2021-12-08$47.50/sh3,630,740$172,460,1500 total(indirect: See Footnotes)
Transactions
  • Sale

    Common Stock

    2021-12-08$47.50/sh20,244,387$961,608,3830 total(indirect: See Footnotes)
  • Sale

    Common Stock

    2021-12-08$47.50/sh15,987,409$759,401,9280 total(indirect: See Footnotes)
  • Sale

    Common Stock

    2021-12-08$47.50/sh934,469$44,387,2780 total(indirect: See Footnotes)
  • Sale

    Common Stock

    2021-12-08$47.50/sh52,884,036$2,511,991,7100 total(indirect: See Footnotes)
  • Sale

    Common Stock

    2021-12-08$47.50/sh359,372$17,070,1700 total(indirect: See Footnotes)
  • Sale

    Common Stock

    2021-12-08$47.50/sh3,630,740$172,460,1500 total(indirect: See Footnotes)
  • Sale

    Common Stock

    2021-12-08$47.50/sh35,622,429$1,692,065,3780 total(indirect: See Footnotes)
  • Sale

    Common Stock

    2021-12-08$47.50/sh3,021,286$143,511,0850 total(indirect: See Footnotes)
  • Sale

    Common Stock

    2021-12-08$47.50/sh157,138$7,464,0550 total(indirect: See Footnotes)
Footnotes (11)
  • [F1]On December 8, 2021, Thermo Fisher Scientific Inc., a Delaware corporation ("Buyer"), acquired the Issuer pursuant to a certain Agreement and Plan of Merger entered into by and among the Issuer, Buyer and Powder Acquisition Corp., a Delaware corporation and wholly-owned subsidiary of Buyer ("Merger Sub"), dated as of April 15, 2021 (the "Merger Agreement"). In accordance with the Merger Agreement, the Issuer merged with and into Merger Sub, with the Issuer surviving such merger as a wholly-owned subsidiary of Buyer (the "Merger"). At the effective time of the Merger, each issued and outstanding share of the Issuer's common stock (other than certain excluded shares) automatically converted into the right to receive $47.50 in cash.
  • [F10]Reflects securities directly held by H&F Associates VIII, L.P. ("H&F VIII Associates", and together with HFCP VIII, HFCP VIII Parallel, HFCP VIII Parallel-A and H&F VIII Executives, the "H&F VIII Funds").
  • [F11]Hellman & Friedman Investors VII, L.P. ("H&F Investors VII") is the general partner of each of the H&F VII Funds. H&F Corporate Investors VII, Ltd. ("H&F VII") is the general partner of H&F Investors VII. Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of each of H&F VII and H&F VIII has investment discretion over the shares held by the H&F VII Funds and the H&F VIII Funds, respectively. Allen R. Thorpe, a member of the board of directors of PPD, Inc. is a member of the boards of directors of H&F VII and H&F VIII.
  • [F2]Reflects securities directly held by Hellman & Friedman Capital Partners VII, L.P. ("HFCP VII").
  • [F3]Reflects securities directly held by Hellman & Friedman Capital Partners VII (Parallel), L.P. ("HFCP VII Parallel").
  • [F4]Reflects securities directly held by HFCP VII (Parallel-A), L.P. ("HFCP VII Parallel-A").
  • [F5]Reflects securities directly held by H&F Executives VII, L.P. ("H&F VII Executives", and together with HFCP VII, HFCP VII Parallel and HFCP VII Parallel-A, the "H&F VII Funds").
  • [F6]Reflects securities directly held by Hellman & Friedman Capital Partners VIII, L.P. ("HFCP VIII").
  • [F7]Reflects securities directly held by Hellman & Friedman Capital Partners VIII (Parallel), L.P. ("HFCP VIII Parallel").
  • [F8]Reflects securities directly held by HFCP VIII (Parallel-A), L.P. ("HFCP VIII Parallel-A").
  • [F9]Reflects securities directly held by H&F Executives VIII, L.P. ("H&F VIII Executives").

Issuer

PPD, Inc.

CIK 0001793294

Entity typeother

Related Parties

1
  • filerCIK 0001405076

Filing Metadata

Form type
4
Filed
Dec 7, 7:00 PM ET
Accepted
Dec 8, 4:53 PM ET
Size
33.5 KB